Skip to main content
. 2022 Apr 13;12:6199. doi: 10.1038/s41598-022-10121-2

Figure 2.

Figure 2

Manhattan plot of genome-wide interaction of current use of menopausal hormone therapy on breast cancer risk. (A) Current MHT use. (B) Current EPT use. Asterisk: red line: log-transformed genome-wide significant threshold at 5 × 10–8; blue line: log-transformed suggestive threshold at 1 × 10–5.